Litcius/Paper detail

Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab

Claudia Landi, Paolo Cameli, Lorenza Vantaggiato, Laura Bergantini, Miriana d’Alessandro, Marco Perruzza, Alfonso Carleo, Enxhi Shaba, Fabrizio Di Giuseppe, Stefania Angelucci, Elena Bargagli, Luca Bini

2020Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics17 citationsDOIOpen Access PDF

Topics & Concepts

MepolizumabBenralizumabMedicineImmunologyAsthmaOxidative stressProinflammatory cytokineInterleukin 5InflammationEosinophilInternal medicineCytokineInterleukinAsthma and respiratory diseasesOccupational exposure and asthmaEosinophilic Esophagitis
Ceruloplasmin and oxidative stress in severe eosinophilic asthma patients treated with Mepolizumab and Benralizumab | Litcius